Diligence memo · auto-generated · as of July 3, 2026
BioTrace Medical, Inc.
BioTrace Medical, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioTrace Medical, Inc. operates in Healthtech, based in MENLO PARK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioTrace Medical, Inc. has raised $22M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2021-03-01.
Most recent recorded round closed around 2021-03-01.
Valuation (modeled)modeled
Provath models BioTrace Medical, Inc. at approximately $191M (range $14M–$891M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.63× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 28 months.
Last raise 5.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 81% of Healthtech peers (2138 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.